Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Australasian Gastro-Intestinal Trials Group · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
advanced
neuroendocrine tumors, advanced, unresectable grade 1 or 2, mid, hind- gut or pancreatic neuroendocrine tumours, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1048144
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.